XAF1 and melanoma: Studies also showed that loss or reduction of XAF1 expression without any corresponding inactivating mutation or deletion, is frequently associated with malignant tumor progression in a variety of cancers including melanoma, gastric, colon and pancreatic cancers [13–18].